Fidelity Investments
NURO

Fidelity Investments’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Fidelity Investments’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-89
Closed -$354 – 5804
2024
Q4 		$354 Sell
89
-16
-15% -$65 ﹤0.01% 5018
2024
Q3 		$431 Buy
+105
New +$385 ﹤0.01% 4981
2024
Q2 		– Sell
-4
Closed -$17 – 5721
2024
Q1 		$17 Buy
+4
New +$14 ﹤0.01% 5213
2021
Q1 		– Sell
-1
Closed – – 4646
2020
Q4 		$0 Buy
+1
New +$16 ﹤0.01% 4365

Other funds holding NURO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Fidelity Investments's NURO Position: Q1 2025 in Review

Fidelity Investments sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q1 2025, closing a stake of 89 shares — an estimated $354 sold.

Fidelity Investments first reported a position in NURO in Q4 2020 and held it in 4 quarters. The position peaked at $431 in Q3 2024. 14 funds tracked by Wall St. Rank hold NURO as of Q1 2025.

  • Fidelity Investments reported no remaining NeuroMetrix, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Fidelity Investments sold 89 NeuroMetrix, Inc. Common Stock shares in Q1 2025, an estimated $354.
  • Fidelity Investments first reported a position in NeuroMetrix, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • Fidelity Investments's NeuroMetrix, Inc. Common Stock position peaked at $431 in Q3 2024.
  • 14 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q1 2025.

Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.